Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Gastric Adenocarcinoma × Neoadjuvant Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 85 Rectal Neoplasms 43 Colorectal Neoplasms 43 Carcinoma, Non-Small-Cell Lung 29 Esophageal Neoplasms 23 Esophageal Squamous Cell Carcinoma 21 Lung Neoplasms 20 Stomach Neoplasms 18 Pancreatic Neoplasms 18 Neoplasms 15 Colonic Neoplasms 14 Carcinoma, Hepatocellular 14 Neoplasm Metastasis 13 Squamous Cell Carcinoma of Head and Neck 12 Prostatic Neoplasms 12 Ovarian Neoplasms 12 Adenocarcinoma Of Esophagus 12 Head and Neck Neoplasms 11 Urinary Bladder Neoplasms 10 Sarcoma 10 Uterine Cervical Neoplasms 9 Osteosarcoma 8 Fallopian Tube Neoplasms 8 Inflammatory Breast Neoplasms 7 Central Nervous System Neoplasms 7 Carcinoma, Intraductal, Noninfiltrating 7 Multiple Myeloma 6 Liver Neoplasms 6 Kidney Neoplasms 6 Carcinoma, Ovarian Epithelial 6

Interventions

camrelizumab 2 spartalizumab 1 pembrolizumab 1 lenvatinib 1 apatinib 1 S 1 (combination) 1 Neoadjuvant Therapy 1 Hyperthermic Intraperitoneal Chemotherapy 1 Docetaxel 1 Albumin-Bound Paclitaxel 1 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02240524 2014-09-15

HIPEC

Affiliated Cancer Hospital & Institute of Guangzhou Medical University

Phase 3 Unknown

Gastrointestinal

Advanced Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡